 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
4 p8 d, C1 ~, A7 N; s. i- P 7 P$ t& R' q- o
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.4 ^8 E/ w3 V" _# a3 d
: R4 U8 t5 h$ R8 w' b
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
* ^8 N( t% o \& O g' K
: ]& V5 D/ u; u K# ?) c
5 \: j/ C1 R- q- u5 Q* c fEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.' F) b1 I# e2 z" S( ^# N
- ~, h0 i3 g/ U# z) N" ~( t; s; j, DThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
" L, {9 M8 z* J4 Y' ?1 b1 Q) M5 A
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.* `3 p3 w4 X; J8 k8 s+ u
9 ~; z9 @3 }! s" @3 F+ K/ dIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
1 k( e8 w/ X% F% w9 O5 Q$ Y8 d4 C2 c, ~6 N) H) r. W
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.: ?1 j1 y) j, q, }6 @
" z) o1 b$ [( W4 x7 L& N, H
"As a scientist, it's one of the highlights of my CAREER," Shan said.5 T3 \- p \9 Y: G7 m) l8 u
7 i- s: t9 |$ B! f% _0 T/ [
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."3 \! c: \4 Y* Z X! K2 S
3 J- b2 [& v8 M& AIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.' t; [. @ Y2 N- Z" d! D0 _
+ a4 O$ r' ^! iGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
1 j2 m9 Q& V; H) w: G
1 D5 J; E. B& z5 o) p$ LThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman." V$ X, _# r; T! T" z
- t& r/ p3 V( z
* A5 V, v" e$ I) ?$ K5 J. ^http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
